What does Stoke Therapeutics, Inc. do?

Jun 22 2025 06:57 PM IST
share
Share Via
Stoke Therapeutics, Inc. is a biotechnology company focused on developing treatments for genetic diseases, with a market cap of $636.60 million and recent net sales of $159 million. Key financial metrics include a P/E ratio of 12.00 and a return on equity of 14.36%.
Overview:
Stoke Therapeutics, Inc. is a biotechnology company that develops treatments for genetic diseases, operating within the Pharmaceuticals & Biotechnology industry and categorized as a micro-cap company.

Financial Snapshot:
Most recent Net Sales: 159 Million (Quarterly Results - Mar 2025)
Most recent Net Profit: 113 Million (Quarterly Results - Mar 2025)
Market-cap: USD 636.60 Million (Micro Cap)

Key Metrics:
P/E: 12.00
Dividend Yield: 0.00%
Debt Equity: -1.01
Return on Equity: 14.36%
Price to Book: 1.82

Contact Details:
Address: 3 Preston Ct, BEDFORD MA: 01730-2379
Tel: 1 781 4308200
Fax: 1 302 5313150
Website: https://www.stoketherapeutics.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News